A Complex Case of Ornithine Transcarbamylase Deficiency in a Patient With Severe Comorbid Conditions

一例合并严重并发症的鸟氨酸转氨甲酰酶缺乏症复杂病例

阅读:2

Abstract

Ornithine transcarbamylase deficiency (OTCD) is the most common urea-cycle disorder, but it is often overlooked in Pakistan. It can present after the neonatal period with symptoms resembling sepsis and significant respiratory alkalosis. We report a 4-month-old boy with fever, lethargy, poor feeding, and loose stools for 5 days. He arrived with a rapid heart rate and quick breathing. His arterial blood gas showed a pH of 7.65, pCO(2) of 14 mmHg, and HCO(3) (-) of 15.5 mmol/L. Plasma ammonia levels were elevated at 78.1 μmol/L (reference range 11-32). A quantitative amino acid test revealed greatly increased glutamate (263 μmol/L; reference range 18-98) with low citrulline (6 μmol/L; reference range 16-32) and a normal ornithine/arginine ratio, which matches the pattern seen in partial OTCD. A contrast-enhanced CT scan of the brain showed widespread leptomeningeal enhancement and mild enlargement of the bifronto-temporal subarachnoid spaces. An echocardiogram found a small secundum atrial septal defect (ASD) and a tiny patent ductus arteriosus (PDA), with normal function in both ventricles. The patient was treated for suspected sepsis and high ammonia levels using sodium benzoate, L-arginine, L-carnitine, micronutrient support, and a low-protein diet based on formula (Basic-P/Morinaga BF-1). This led to steady improvements in his clinical condition and blood work. This case highlights three key points for resource-limited settings: (i) check ammonia levels early in any infant with unexplained encephalopathy and respiratory alkalosis; (ii) a low-citrulline/normal-ornithine profile should prompt evaluation for OTCD, even with mild hyperammonemia; and (iii) starting nitrogen-scavenging therapy and adjusting dietary protein can prevent the need for dialysis. Documenting these presentations helps raise awareness in the region and emphasizes the importance of access to confirmatory molecular testing and family counseling when newborn screening is not available.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。